However current therapy of kidney disease almost always entails the use of multiple agents, and it is possible that TRPC6 inhibition would be more effective if other targets were simultaneously blocked, especially in the case of diabetic nephropathy or hypertension. Here, TRPC6 is linked to kidney disorder.